Science of Identity Foundation Contributes to Hurricane Irma Relief Efforts
HONOLULU, Oct. 10, 2017 /PRNewswire/ -- In response to the devastation caused by Hurricane Irma, Science of Identity Foundation has made a donation to the Hurricane Irma relief fund, and is also urging people to contribute whatever they can to ongoing relief efforts and collection drives.
Science of Identity Foundation president Jeanie Bishop said, "This was the most catastrophic natural disaster in recent memory. Our founder Jagad Guru Siddhaswarupananda stresses that a true yogi is one who cares about both the material and spiritual well-being of others. So this is a perfect example of putting yoga principles into practical good works."
Founded in 1977 by Jagad Guru Siddhaswarupananda, the Science of Identity Foundation teaches ancient yoga wisdom, mantra meditation, and other techniques to help individuals achieve mental, physical, and spiritual well-being.
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...
